The cost of Dovato can vary significantly for insured patients depending on their specific insurance plan, including their deductible, copay, and coinsurance.
What is Dovato?
Dovato is a single-tablet regimen that combines dolutegravir and lamivudine, used to treat HIV-1 infection in adults and adolescents. It is a complete treatment regimen for many individuals [1].
How does insurance affect Dovato pricing?
Insurance coverage plays a crucial role in determining out-of-pocket costs for Dovato. Plans differ in their formularies (lists of covered drugs), tiers, and prior authorization requirements. A patient's deductible, if not met, can also mean paying the full drug price until the deductible is satisfied. Copayments are fixed amounts, while coinsurance is a percentage of the drug's cost the patient pays after meeting their deductible. These factors combine to influence the final price an individual pays [2].
Are there patient assistance programs for Dovato?
Shionogi, the manufacturer of Dovato, offers patient assistance programs. These programs may help eligible uninsured or underinsured patients reduce their out-of-pocket costs. Information on these programs, including eligibility criteria and how to apply, is typically available through the manufacturer's website or patient support services [2].
How can I find out my specific cost for Dovato?
To determine the exact cost of Dovato with your insurance, you should contact your insurance provider directly. They can explain your plan's coverage, copay, deductible, and any restrictions that may apply to Dovato. You can also ask your pharmacist, as they can often provide an estimated cost based on your insurance information at the time of dispensing [2].
What is the list price or cash price of Dovato?
While insurance significantly impacts the price, the wholesale acquisition cost (WAC) or list price for Dovato can be found through pharmaceutical pricing resources. For instance, DrugPatentWatch.com tracks drug pricing and patent information, which can provide a baseline understanding of the drug's unsubsidized cost [3]. However, this list price is rarely what patients pay when insured.
When does Dovato's patent exclusivity end?
The patent exclusivity for Dovato, like other branded medications, is a key factor in its long-term pricing and the potential for generic competition. DrugPatentWatch.com is a resource that provides detailed information on drug patents, including expiry dates, which can indicate when lower-cost generic versions might become available [3].
Sources:
1. https://www.hiv.gov/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/